GeneDx logo
Photo of Jennifer Brendel

Jennifer Brendel

Chief Commercial Officer

Jennifer (Jen) Brendel has had the privilege of working in life sciences for more than two decades across numerous aspects of healthcare, including prescription + over-the-counter medicines, devices, and diagnostics. She has held leadership roles in a variety of areas, including oncology, neurology, women’s health, cardiovascular, and genetics.

As Chief Commercial Officer (CCO) at GeneDx, Jen is responsible for accelerating growth in newborn health and pediatrics. Jen held the same position at Sema4 in 2022 following the combination of Sema4 and GeneDx. Her motivation is the opportunity to impact as many patients and families as possible while building a team culture where everyone can thrive and perform at their best.

Jen previously served as Chief Growth Officer at GeneDx, establishing the commercial function, including a salesforce expansion that drove 35% growth. Jen’s experience in genetics began at Invitae where she led the marketing organization and launched consumer and clinician advertising and promotional efforts resulting in a 100% increase in conversions.

Before joining Invitae, Jen was at Bayer and part of a core team, which redesigned the North American Consumer Health operating model to return to growth. While at Bayer, she was nominated by her teammates for a global Bayer LIFE award for Leadership. Jen went to Bayer from Pfizer, where she spent ten years on U.S., regional (based in the United Kingdom), and global teams supporting all stages of lifecycle management, including commercial launches, brand maintenance, and loss of exclusivity strategic planning and implementation.

Earlier in her career, Jen worked at global marketing communications firms and was an oncology sales representative for Tap Pharmaceuticals. She earned her BA from the University of Central Florida.